AEON
AEON Biopharma, Inc. Class A Common Stock (AEON)
$16
About AEON Biopharma, Inc. Class A Common Stock (AEON)
AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Details
Daily high
$0.22
Daily low
$0.13
Price at open
$0.22
52 Week High
$1.45
52 Week Low
$0.13
Market cap
12.3M
Dividend yield
-
Volume
2.7M
Avg. volume
960,005
P/E ratio
-.06
AEON Biopharma, Inc. Class A Common Stock News
Details
Daily high
$0.22
Daily low
$0.13
Price at open
$0.22
52 Week High
$1.45
52 Week Low
$0.13
Market cap
12.3M
Dividend yield
-
Volume
2.7M
Avg. volume
960,005
P/E ratio
-.06